Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Pediatrics

Standard of Care Treatment for IGS

At a Glance

Imerslund-Gräsbeck syndrome is treated with lifelong vitamin B12 replacement, usually through injections because the intestine cannot absorb enough B12 from food. Blood counts often improve, but nerve recovery varies and protein in the urine may persist, so regular monitoring is important.

Because Imerslund-Gräsbeck syndrome (IGS) is caused by a permanent genetic inability to absorb Vitamin B12 from food, the goal of treatment is straightforward: bypass the gut entirely to deliver the vitamin directly where it is needed [1][2]. While the diagnosis of a lifelong condition can be daunting, the treatment for IGS is generally very effective [3].

The Standard of Care: B12 Injections

The accepted treatment for IGS is lifelong Vitamin B12 (cobalamin) replacement therapy [4][5]. Because the receptor in the small intestine is broken, traditional dietary Vitamin B12 or routine supplements cannot be relied upon [2].

  • The Route: Injections—delivered into the muscle (intramuscular) or just under the skin (subcutaneous)—are the most reliable way to ensure the body receives enough B12 [6][7]. Hydroxocobalamin and cyanocobalamin are common forms used.
  • The Schedule: Treatment typically begins with a loading phase to quickly refill the body’s depleted stores [8]. Once levels are stabilized, your child will transition to a maintenance phase [5]. The product, dose, route, loading intensity, and maintenance interval vary with age, severity, local practice, and the individual’s response [1]. Your specialist will determine the specific regimen. Do not change the dosage or skip injections without consulting your care team. If you miss a dose, contact your team for instructions on what to do next.

A Note on Oral Therapy

You may hear about high-dose oral Vitamin B12 as an alternative. While some B12 can seep across the gut lining even without the receptor, high-dose oral treatment is a specialist-supervised option for selected patients, not something to trial independently [9]. Most pediatric IGS success stories are based on injections, and oral therapy requires extremely strict adherence and frequent blood monitoring to ensure levels don’t drop [4][9]. If oral therapy fails, the deficiency can return, potentially causing irreversible neurological damage before symptoms are noticed [10].

Response to Treatment

Once treatment begins, you can expect to see improvements:

  • Blood Recovery: Hematologic response often begins with a reticulocyte response within days, and hemoglobin improvement over the following weeks, though full normalization may take longer [5][8].
  • Neurological Gains: Improvements in coordination or energy levels can begin within weeks [11]. However, neurological recovery is highly variable and depends on how severe and how long the deficiency was present. Recovery may take months or remain incomplete, so do not expect rapid full recovery of walking or coordination in all cases [11][6].

Why the Protein Persists

A common point of confusion is that while the anemia goes away, the proteinuria (protein in the urine) almost always persists [2][4].

This does not mean the B12 treatment is failing. It happens because the same genetic defect that breaks the gut receptor also breaks the mechanism in the kidneys that normally reabsorbs filtered protein [12][13]. While this protein loss is a permanent feature of IGS, evidence suggests that kidney function is usually preserved [14][1]. Your child’s care team will recommend regular kidney monitoring as a standard precaution [4].

Common questions in this guide

What is the usual treatment for Imerslund-Gräsbeck syndrome?
The usual treatment is lifelong vitamin B12 replacement, most often given by injection into a muscle or under the skin. Because IGS affects the intestinal receptor needed to absorb B12, food and ordinary supplements cannot be relied on to prevent deficiency.
How are B12 injections started and continued for IGS?
Treatment often begins with a loading phase to restore B12 stores, followed by maintenance injections. The dose and timing depend on age, severity, treatment response, and local practice, so the specialist should set the schedule.
Can children with IGS take oral B12 instead of injections?
High-dose oral B12 may be an option for selected patients, but only with specialist supervision, strict adherence, and frequent blood tests. Injections are the more reliable approach, and oral treatment should not be started or changed independently.
How soon should my child’s anemia or neurological symptoms improve?
Blood production often begins to respond within days, and hemoglobin may improve over the following weeks, although full normalization can take longer. Energy and coordination may improve within weeks, but nerve recovery varies and can take months or remain incomplete.
Why can protein in the urine continue after B12 treatment?
IGS can affect a kidney mechanism that normally reabsorbs protein, so protein in the urine may persist even when the anemia improves. This does not usually mean B12 treatment is failing; kidney function is often preserved, but regular monitoring is recommended.
What monitoring does a child with IGS need during treatment?
Care teams commonly recheck blood counts and B12 levels to confirm that replacement is working. They also recommend regular kidney monitoring, which may include blood pressure and measures of kidney filtration such as GFR, on a schedule set for your child.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific B12 preparation (hydroxocobalamin or cyanocobalamin) do you recommend for my child?
  2. 2.How many 'loading' doses will my child need initially, and what will the long-term maintenance schedule look like?
  3. 3.When will we re-test my child's CBC and B12 levels to confirm the treatment is working effectively?
  4. 4.Is our child a candidate for high-dose oral B12, or do you recommend staying with injections as the 'gold standard' for now?
  5. 5.Since the protein in the urine may not go away, what specific kidney monitoring (such as blood pressure or GFR) will we need to do annually?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Profound vitamin D deficiency in four siblings with Imerslund-Grasbeck syndrome with homozygous CUBN mutation.

    Ciancio JIR, Furman M, Banka S, Grunewald S

    JIMD reports 2019; (49(1)):43-47 doi:10.1002/jmd2.12072.

    PMID: 31497480
  2. 2

    Clinical and molecular characteristics of imerslund-gräsbeck syndrome: First report of a novel Frameshift variant in Exon 11 of AMN gene.

    Elshinawy M, Gao HH, Al-Nabhani DM, Al-Thihli KA

    International journal of laboratory hematology 2021; (43(5)):1009-1015 doi:10.1111/ijlh.13473.

    PMID: 33491342
  3. 3

    Imerslund-Gräsbeck syndrome: a comprehensive review of reported cases.

    Kingma SDK, Neven J, Bael A, et al.

    Orphanet journal of rare diseases 2023; (18(1)):291 doi:10.1186/s13023-023-02889-x.

    PMID: 37710296
  4. 4

    [Clinical analysis of two brothers with Imerslund-Gräsbeck syndrome].

    Xi WW, Cao L, Huo HL, et al.

    Zhonghua yi xue za zhi 2021; (101(40)):3351-3354 doi:10.3760/cma.j.cn112137-20210709-01537.

    PMID: 34758537
  5. 5

    [IMERSLUND-GRÄSBECK SYNDROME CONGENITAL FORM OF VITAMIN B12 DEFICIENCY ANEMIA].

    Kvezereli-Kopadze M, Mtvarelidze Z

    Georgian medical news 2019; 45-48.

    PMID: 31322513
  6. 6

    A child with Imerslund-Gräsbeck syndrome concealed by co-existing α-thalassaemia presenting with subacute combined degeneration of the spinal cord: a case report.

    Arunath V, Hoole TJ, Rathnasri A, et al.

    BMC pediatrics 2021; (21(1)):41 doi:10.1186/s12887-021-02499-1.

    PMID: 33461510
  7. 7

    Diagnosis and treatment of vitamin B12 deficiency in children.

    Kanvinde P, Khurana R, Mudaliar S

    Frontiers in nutrition 2026; (13()):1883501 doi:10.3389/fnut.2026.1883501.

    PMID: 42591473
  8. 8

    Imerslund-Gräsbeck syndrome presenting with a 12-year history of intermittent proteinuria and anemia: a case from the Middle East.

    Makrooni R, Rahimi Darehbagh R, Karimi A, Moradveisi B

    BMC pediatrics 2025; (25(1)):913 doi:10.1186/s12887-025-06284-2.

    PMID: 41199191
  9. 9

    Imerslund-Gräsbeck syndrome in a child with a novel compound heterozygous mutations in the AMN gene: a case report.

    Zhang D, Liu S, Xi B, et al.

    Italian journal of pediatrics 2024; (50(1)):191 doi:10.1186/s13052-024-01757-z.

    PMID: 39334390
  10. 10

    VIT. B12 DEFICIENCY IN CHILDREN (IMERSLUND-GRÄSBECK SYNDROME IN TWO PAIRS OF SIBLINGS).

    Krzemień G, Turczyn A, Szmigielska A, Roszkowska-Blaim M

    Developmental period medicine 2015; (19(3 Pt 2)):351-5.

    PMID: 26958680
  11. 11

    Acute cerebellar ataxia as the first manifestation of Imerslund-Gräsbeck syndrome.

    Eslamiyeh H

    Iranian journal of child neurology 2021; (15(4)):105-108 doi:10.22037/ijcn.v15i4.27482.

    PMID: 34782847
  12. 12

    Amnionless-mediated glycosylation is crucial for cell surface targeting of cubilin in renal and intestinal cells.

    Udagawa T, Harita Y, Miura K, et al.

    Scientific reports 2018; (8(1)):2351 doi:10.1038/s41598-018-20731-4.

    PMID: 29402915
  13. 13

    Structural assembly of the megadalton-sized receptor for intestinal vitamin B12 uptake and kidney protein reabsorption.

    Larsen C, Etzerodt A, Madsen M, et al.

    Nature communications 2018; (9(1)):5204 doi:10.1038/s41467-018-07468-4.

    PMID: 30523278
  14. 14

    Benign proximal tubular albuminuria due to AMN mutation: A challenging presentation of Imerslund-Gräsbeck syndrome.

    Pul S, Güven S, Çiçek N, et al.

    Pediatric nephrology (Berlin, Germany) 2026; (41(4)):999-1001 doi:10.1007/s00467-025-07052-1.

    PMID: 41236624

This page explains standard treatment for Imerslund-Gräsbeck syndrome for informational purposes only and does not constitute medical advice. Your child’s specialist should choose the B12 regimen and monitor blood counts, vitamin levels, neurological recovery, and kidney health.

Get notified when new evidence is published on Imerslund-Gräsbeck syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.